| Nedd8 on cullin: building an expressway to protein destruction ZQ Pan, A Kentsis, DC Dias, K Yamoah, K Wu Oncogene 23 (11), 1985-1997, 2004 | 510 | 2004 |
| Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study MJ Morris, SP Rowe, MA Gorin, L Saperstein, F Pouliot, D Josephson, ... Clinical Cancer Research 27 (13), 3674-3682, 2021 | 320 | 2021 |
| Testicular cancer, version 2.2020, NCCN clinical practice guidelines in oncology T Gilligan, DW Lin, R Aggarwal, D Chism, N Cost, IH Derweesh, ... Journal of the National Comprehensive Cancer Network 17 (12), 1529-1554, 2019 | 306 | 2019 |
| Commensal bacteria modulate cullin‐dependent signaling via generation of reactive oxygen species A Kumar, H Wu, LS Collier‐Hyams, JM Hansen, T Li, K Yamoah, ZQ Pan, ... The EMBO journal 26 (21), 4457-4466, 2007 | 305 | 2007 |
| Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial M Roach, J Moughan, CAF Lawton, AP Dicker, KL Zeitzer, EM Gore, ... The lancet oncology 19 (11), 1504-1515, 2018 | 240 | 2018 |
| DEN1 is a dual function protease capable of processing the C terminus of Nedd8 and deconjugating hyper-neddylated CUL1 K Wu, K Yamoah, G Dolios, T Gan-Erdene, P Tan, A Chen, C Lee, N Wei, ... Journal of Biological Chemistry 278 (31), 28882-28891, 2003 | 222 | 2003 |
| Novel biomarker signature that may predict aggressive disease in African American men with prostate cancer K Yamoah, MH Johnson, V Choeurng, FA Faisal, K Yousefi, Z Haddad, ... Journal of Clinical Oncology 33 (25), 2789-2796, 2015 | 155 | 2015 |
| Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss L Sun, S Vukicevic, R Baliram, G Yang, R Sendak, J McPherson, LL Zhu, ... Proceedings of the National Academy of Sciences 105 (11), 4289-4294, 2008 | 151 | 2008 |
| miRNAs associated with prostate cancer risk and progression HN Luu, HY Lin, KD Sørensen, OO Ogunwobi, N Kumar, G Chornokur, ... BMC urology 17, 1-18, 2017 | 118 | 2017 |
| Racial differences in genomic profiling of prostate cancer BA Mahal, M Alshalalfa, KH Kensler, I Chowdhury-Paulino, P Kantoff, ... New England Journal of Medicine 383 (11), 1083-1085, 2020 | 113 | 2020 |
| Autoinhibitory regulation of SCF-mediated ubiquitination by human cullin 1's C-terminal tail K Yamoah, T Oashi, A Sarikas, S Gazdoiu, R Osman, ZQ Pan Proceedings of the National Academy of Sciences 105 (34), 12230-12235, 2008 | 113 | 2008 |
| Treatment delays, race, and outcomes in head and neck cancer AO Naghavi, MI Echevarria, TJ Strom, YA Abuodeh, KA Ahmed, ... Cancer epidemiology 45, 18-25, 2016 | 106 | 2016 |
| Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC … S Gillessen, A Bossi, ID Davis, J de Bono, K Fizazi, ND James, N Mottet, ... European journal of cancer 185, 178-215, 2023 | 99 | 2023 |
| Two novel susceptibility loci for prostate cancer in men of African ancestry DV Conti, K Wang, X Sheng, JT Bensen, DJ Hazelett, MB Cook, SA Ingles, ... JNCI: Journal of the National Cancer Institute 109 (8), djx084, 2017 | 99 | 2017 |
| Management of patients with advanced prostate cancer: report from the Advanced Prostate Cancer Consensus Conference 2021 S Gillessen, A Armstrong, G Attard, TM Beer, H Beltran, A Bjartell, A Bossi, ... European urology 82 (1), 115-141, 2022 | 93 | 2022 |
| Racial and ethnic disparities in prostate cancer outcomes in the veterans affairs health care system K Yamoah, KM Lee, S Awasthi, PR Alba, C Perez, TR Anglin-Foote, ... JAMA Network Open 5 (1), e2144027-e2144027, 2022 | 93 | 2022 |
| Management of patients with advanced prostate cancer. Part I: intermediate-/high-risk and locally advanced disease, biochemical relapse, and side effects of hormonal treatment … S Gillessen, A Bossi, ID Davis, J de Bono, K Fizazi, ND James, N Mottet, ... European urology 83 (3), 267-293, 2023 | 91 | 2023 |
| High dose rate brachytherapy boost for prostate cancer: a systematic review NG Zaorsky, LA Doyle, K Yamoah, JA Andrel, EJ Trabulsi, MD Hurwitz, ... Cancer treatment reviews 40 (3), 414-425, 2014 | 83 | 2014 |
| Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies AO Naghavi, MI Echevarria, GD Grass, TJ Strom, YA Abuodeh, KA Ahmed, ... Cancer 122 (22), 3529-3537, 2016 | 81 | 2016 |
| Evidence that calcineurin is required for the genesis of bone-resorbing osteoclasts L Sun, Y Peng, N Zaidi, LL Zhu, J Iqbal, K Yamoah, X Wang, P Liu, E Abe, ... American Journal of Physiology-Renal Physiology 292 (1), F285-F291, 2007 | 80 | 2007 |
